Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 150

1.

Optimising the changing role of the community pharmacist: a randomised trial of the impact of audit and feedback.

Winslade N, Eguale T, Tamblyn R.

BMJ Open. 2016 May 20;6(5):e010865. doi: 10.1136/bmjopen-2015-010865.

2.
3.

The (cost-)effectiveness of a patient-tailored intervention programme to enhance adherence to antihypertensive medication in community pharmacies: study protocol of a randomised controlled trial.

van der Laan DM, Elders PJ, Boons CC, Bosmans JE, Nijpels G, Hugtenburg JG.

Trials. 2017 Jan 19;18(1):29. doi: 10.1186/s13063-016-1696-3.

4.

Impact of a community pharmacists' hypertension-care service on medication adherence. The AFenPA study.

Fikri-Benbrahim N, Faus MJ, Martínez-Martínez F, Sabater-Hernández D.

Res Social Adm Pharm. 2013 Nov-Dec;9(6):797-805. doi: 10.1016/j.sapharm.2012.12.006. Epub 2013 Feb 4.

PMID:
23391845
5.

Improving refill adherence and hypertension control in black patients: Wisconsin TEAM trial.

Svarstad BL, Kotchen JM, Shireman TI, Brown RL, Crawford SY, Mount JK, Palmer PA, Vivian EM, Wilson DA.

J Am Pharm Assoc (2003). 2013 Sep-Oct;53(5):520-9. doi: 10.1331/JAPhA.2013.12246.

6.

Effectiveness of a pharmacist-driven intervention in COPD (EPIC): study protocol for a randomized controlled trial.

Davis E, Marra C, Gamble JM, Farrell J, Lockyer J, FitzGerald JM, Abu-Ashour W, Gillis C, Hawboldt J.

Trials. 2016 Oct 13;17(1):502.

7.

The effect of providing feedback on inhaler technique and adherence from an electronic audio recording device, INCA®, in a community pharmacy setting: study protocol for a randomised controlled trial.

O'Dwyer SM, MacHale E, Sulaiman I, Holmes M, Hughes C, D'Arcy S, Rapcan V, Taylor T, Boland F, Bosnic-Anticevich S, Reilly RB, Ryder SA, Costello RW.

Trials. 2016 May 4;17(1):226. doi: 10.1186/s13063-016-1362-9.

8.

Evaluation of a community pharmacy-based intervention for improving patient adherence to antihypertensives: a randomised controlled trial.

Lau R, Stewart K, McNamara KP, Jackson SL, Hughes JD, Peterson GM, Bortoletto DA, McDowell J, Bailey MJ, Hsueh A, George J.

BMC Health Serv Res. 2010 Feb 5;10:34. doi: 10.1186/1472-6963-10-34.

9.

The Medicines Advice Service Evaluation (MASE): a randomised controlled trial of a pharmacist-led telephone based intervention designed to improve medication adherence.

Lyons I, Barber N, Raynor DK, Wei L.

BMJ Qual Saf. 2016 Oct;25(10):759-69. doi: 10.1136/bmjqs-2015-004670. Epub 2016 Jan 11.

10.

Empowering pharmacists in asthma management through interactive SMS (EmPhAsIS): study protocol for a randomized controlled trial.

De Vera MA, Sadatsafavi M, Tsao NW, Lynd LD, Lester R, Gastonguay L, Galo J, FitzGerald JM, Brasher P, Marra CA.

Trials. 2014 Dec 13;15:488. doi: 10.1186/1745-6215-15-488.

11.

A Multichannel Medication Adherence Intervention Influences Patient and Prescriber Behavior.

Leslie RS, Gilmer T, Natarajan L, Hovell M.

J Manag Care Spec Pharm. 2016 May;22(5):526-38. doi: 10.18553/jmcp.2016.22.5.526.

12.

Randomised evaluation of the Italian medicines use review provided by community pharmacists using asthma as a model (RE I-MUR).

Manfrin A, Thomas T, Krska J.

BMC Health Serv Res. 2015 Apr 21;15:171. doi: 10.1186/s12913-015-0791-6.

13.

Community Pharmacists Assisting in Total Cardiovascular Health (CPATCH): A Cluster-Randomized, Controlled Trial Testing a Focused Adherence Strategy Involving Community Pharmacies.

Blackburn DF, Evans CD, Eurich DT, Mansell KD, Jorgenson DJ, Taylor JG, Semchuk WM, Shevchuk YM, Remillard AJ, Tran DA, Champagne AP.

Pharmacotherapy. 2016 Oct;36(10):1055-1064. doi: 10.1002/phar.1831. Epub 2016 Sep 25.

PMID:
27581815
14.

Pharmacist-led intervention study to improve drug therapy in asthma and COPD patients.

Ottenbros S, Teichert M, de Groot R, Griens F, Sodihardjo F, Wensing M, de Gier JJ.

Int J Clin Pharm. 2014 Apr;36(2):336-44. doi: 10.1007/s11096-013-9887-4. Epub 2013 Dec 1.

PMID:
24293335
15.

A multifaceted pharmacist intervention to improve antihypertensive adherence: a cluster-randomized, controlled trial (HAPPy trial).

Stewart K, George J, Mc Namara KP, Jackson SL, Peterson GM, Bereznicki LR, Gee PR, Hughes JD, Bailey MJ, Hsueh YA, McDowell JM, Bortoletto DA, Lau R.

J Clin Pharm Ther. 2014 Oct;39(5):527-34. doi: 10.1111/jcpt.12185. Epub 2014 Jun 19.

PMID:
24943987
16.

Impact of community pharmacists' interventions on asthma self-management care.

Kovačević M, Ćulafić M, Jovanović M, Vučićević K, Kovačević SV, Miljković B.

Res Social Adm Pharm. 2018 Jun;14(6):603-611. doi: 10.1016/j.sapharm.2017.07.007. Epub 2017 Jul 25.

PMID:
28778676
17.

Evaluation of the first year of a pilot program in community pharmacy: HIV/AIDS medication therapy management for Medi-Cal beneficiaries.

Hirsch JD, Rosenquist A, Best BM, Miller TA, Gilmer TP.

J Manag Care Pharm. 2009 Jan-Feb;15(1):32-41.

18.

A cluster randomised control trial to evaluate the effectiveness and cost-effectiveness of the Italian medicines use review (I-MUR) for asthma patients.

Manfrin A, Tinelli M, Thomas T, Krska J.

BMC Health Serv Res. 2017 Apr 24;17(1):300. doi: 10.1186/s12913-017-2245-9.

19.

Supporting adherence for people starting a new medication for a long-term condition through community pharmacies: a pragmatic randomised controlled trial of the New Medicine Service.

Elliott RA, Boyd MJ, Salema NE, Davies J, Barber N, Mehta RL, Tanajewski L, Waring J, Latif A, Gkountouras G, Avery AJ, Chuter A, Craig C.

BMJ Qual Saf. 2016 Oct;25(10):747-58. doi: 10.1136/bmjqs-2015-004400. Epub 2015 Dec 8.

20.

Evaluation of Pharmacists' Work in a Physician-Pharmacist Collaborative Model for the Management of Hypertension.

Isetts BJ, Buffington DE, Carter BL, Smith M, Polgreen LA, James PA.

Pharmacotherapy. 2016 Apr;36(4):374-84. doi: 10.1002/phar.1727. Epub 2016 Mar 18.

Supplemental Content

Support Center